Mecasermin Completed Phase 3 Trials for Amyotrophic Lateral Sclerosis (ALS) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00035815Insulin-like Growth Factor-1 in Amyotrophic Lateral Sclerosis (ALS) Trial